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ABSTRACT
The exosome complex is a key component of the
cellular RNA surveillance machinery and is required
for normal 3’ end processing of many stable RNAs.
Exosome activity requires additional factors such
as the Ski or TRAMP complexes to activate the
complex or facilitate substrate binding. Rrp47p
promotes the catalytic activity of the exosome
component Rrp6p, but its precise function is
unknown. Here we show that recombinant Rrp47p
is expressed as an apparently hexameric complex
that specifically binds structured nucleic acids.
Furthermore, pull-down assays demonstrated that
Rrp47p interacts directly with the N-terminal region
of Rrp6p that contains the functionally uncharacter-
ized PMC2NT domain. Strains expressing a mutant
form of Rrp6p lacking the N-terminal region failed to
accumulate Rrp47p at normal levels, exhibited
a slow growth phenotype characteristic of rrp47-"
mutants and showed RNA processing defects
consistent with loss of Rrp47p function. These
findings suggest Rrp47p promotes Rrp6p activity
by facilitating binding via the PMC2NT domain to
structural elements within RNA. Notably, character-
ized Rrp6p substrates such as the 5.8S+30 species
are predicted to contain helices at their 3’ termini,
while others such as intergenic or antisense cryptic
unstable transcripts could potentially form exten-
sive double-stranded molecules with overlapping
mRNAs.
INTRODUCTION
RNAs are subjected to quality control mechanisms,
known collectively as RNA surveillance, which remove
transcripts arising through errors in DNA replication,
transcriptional ﬁdelity, ribonucleoprotein particle
assembly or RNA processing. A major component of
the cellular surveillance machinery is the exosome 30->50
exonuclease complex, which degrades unwanted trans-
cripts both in nuclear RNA surveillance programmes
and in translation-coupled events (1–3). In addition,
the exosome precisely generates the 30 termini of mature
RNAs such as 5.8S rRNA, small nucleolar RNAs
(snoRNAs) that function in pre-rRNA processing and
small nuclear RNAs (snRNA) that facilitate pre-mRNA
splicing (4,5). The exosome also degrades the non-coding
50 external transcribed spacer (50 ETS) fragment that is
released during pre-rRNA processing (6), and functions
in normal mRNA turnover pathways (7,8).
Recent high-resolution crystal structures of exosome
complexes from archaeal, yeast and human origin (9–11)
have established that the conserved core complex
comprises a hexameric ring of subunits homologous to
Escherichia coli RNase PH, with three further proteins
containing S1 and KH RNA-binding domains located
at equivalent positions on one face of the ring. This
arrangement of the exosome core complex is analogous to
that of PNPase (12), a component of the degradosome
complex that also functions in both mRNA degradation
and RNA processing pathways in prokaryotes (13).
The core appears to play an important structural role,
with all nine components of the yeast or human complex
being required for structural integrity of the complex
(11,14). The eukaryotic exosome contains the salt-labile
30->50 exonuclease, Rrp44p/Dis3p (15), and the 30->50
exonuclease Rrp6p (16,17), neither of which are present in
the archaeal exosome (18).
A hallmark of the exosome complex is that it requires
additional proteins to facilitate its exonucleolytic activity
in either RNA processing or RNA surveillance pathways.
Exosome function in mRNA turnover and cytoplasmic
mRNA surveillance pathways requires the associated
putative GTPase Ski7p and the Ski complex, comprising
the putative RNA helicase Ski2p, Ski3p and Ski8p (7,19).
Nuclear RNA surveillance functions require a TRAMP
complex, consisting of the putative RNA helicase Mtr4p,
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logous RNA-binding proteins Air1p or Air2p (20–24).
Similarly, exosome functions mediated by Rrp6p are
dependent upon the small basic protein Rrp47p/Lrp1p
(25–27).
Rrp6p is a member of the DEDD family of 30->50
exonucleases (28) that includes enzymes that act on both
RNA and DNA by a hydrolytic mechanism involving two
divalent metal ions (29). Rrp6p also contains a helicase
and RNase D C-terminal (HRDC) domain that has
been proposed to be an RNA-binding domain (30,31).
However, Rrp6p itself does not show stable RNA binding
in vitro (32). In addition to the catalytic and HRDC
domains, Rrp6p contains a C-terminal region that
contains nuclear localization signals (32) and an unchar-
acterized N-terminal domain denoted PMC2NT (33).
RRP6 was ﬁrst characterized as a suppressor mutant
of a temperature-sensitive (ts) allele of the PAP1 gene
encoding the nuclear canonical poly(A) polymerase (34).
Haploid yeast cells with an rrp6- null allele are viable
but show slow growth and a ts-lethal phenotype. Strains
lacking Rrp6p have defects in stable RNA synthesis,
including the accumulation of 30 extended processing
intermediates of 5.8S rRNA, snRNAs and box C/D
snoRNAs (4,34) and the accumulation of polyadenylated
RNAs (5,35). In addition to its role in stable RNA
processing, rrp6- mutants are also defective in nuclear
mRNA surveillance pathways and in the retention of
transcripts at the site of transcription (36, and references
therein). Mutations of conserved residues in the catalytic
domain of Rrp6p cause a loss of function and a cold-
sensitive growth phenotype, while mutations within the
HRDC domain show only mild RNA processing defects
(32,37). The role of the N-terminal PMC2NT domain has
not yet been addressed.
The nuclear yeast protein Rrp47p/Lrp1p was identiﬁed
as a component of the exosome that remained associated
with Rrp6p-containing complexes through aﬃnity chro-
matography puriﬁcation. Northern blot hybridization
experiments and microarray analyses on RNA from
rrp47- strains demonstrated that Rrp47p is required
at the same step in stable RNA processing pathways
as Rrp6p (25,26). Subsequent studies revealed a similar
relationship between Rrp47p and Rrp6p in nuclear
mRNA surveillance pathways (27,38). The absence of
Rrp47p has no signiﬁcant eﬀect on Rrp6p expression
levels or the ability of Rrp6p to bind to the exosome (25).
The similar but weaker eﬀects on stable RNA processing
observed with rrp47- mutants, compared with rrp6-
mutants, the non-additive phenotype of rrp47-D rrp6-
double mutants and the lack of homology between
Rrp47p and any characterized exonuclease led to the
suggestion that Rrp47p speciﬁcally promotes the exo-
nuclease activity of Rrp6p (25). In contrast to rrp6-
mutants, cells lacking Rrp47p do not show a ts-lethal
growth phenotype. Therefore, Rrp6p has at least one
Rrp47p-independent function that is required for optimal
growth.
While Rrp47p has been shown both biochemically and
genetically to function together with Rrp6p, its precise
function in RNA processing and surveillance pathways
is not clear. Here we report that yeast Rrp47p is a nucleic
acid-binding protein that speciﬁcally binds structured
nucleic acids. Furthermore, we demonstrate that Rrp47p
interacts directly with the catalytic exosome component
Rrp6p via its N-terminal PMC2NT domain. Yeast strains
expressing a truncated version of Rrp6p lacking the
N-terminal region that contains the PMC2NT domain
broadly exhibit the same growth phenotypes and stable
RNA processing defects as rrp47- mutants, and fail to
accumulate normal levels of Rrp47p. These results provide
a mechanistic explanation for how Rrp47p promotes the
activity of Rrp6p in degrading or processing structured
substrates such as the 30 extended ‘5.8S+30’ rRNA
processing intermediate, snoRNA precursors and inter-
genic pol II transcripts.
MATERIALS AND METHODS
Plasmids
To express recombinant His-tagged Rrp47p, an NcoI
restriction site was introduced at the initiation codon by
PCR and the ampliﬁed gene was cloned into pRSETB
(Invitrogen) as an NcoI–HindIII fragment (p238).
The full-length recombinant GST–Rrp6p expression
construct (p243) was made by successively subcloning
BamHI–BamHI and KpnI–EcoRI fragments from the
yeast expression construct pEG-p65 (17) (kindly provided
by J.S. Butler) into pGEX-2T (GE Healthcare). Digestion
of p243 with KpnI, treatment with T4 DNA polymerase,
digestion with StuI and religation generated the rrp6212-
721 construct (p245). Digestion of p243 with BglII and
religation generated the rrp642-450 construct (p246).
To express the PMC2NT domain of Rrp6p as a GST
fusion protein, the N-terminal region of RRP6 encoding
residues 13–102 was ampliﬁed from genomic yeast DNA
by PCR and cloned into pGEX-2T as a BamHI–EcoRI
fragment, yielding p249. GST fusions of extended variants
of the PMC2NT domain (P176X, p256; L197X, p257)
were generated by site-directed mutagenesis of p245 using
the Quick-change mutagenesis kit (Stratagene). To express
Rrp6p lacking the N-terminal region in E. coli, p243 was
digested with KpnI, treated with T4 polymerase and
digested with EcoRI. The released fragment was cloned
into pGEX-2T after digestion with BamHI, treatment
with klenow and subsequent digestion with EcoRI.
The incurred frameshift at the BamHI–KpnI junction
was then removed by deleting the 30 C residue of the
BamHI site by site-directed mutagenesis, as above,
generating the rrp61-212 construct (p266). To express
an rrp6 mutant lacking the N-terminal region in yeast, the
1.8kb KpnI–EcoRI fragment of RRP6 was cloned in
frame behind two tandem copies of the z domain of
Staphylococcus aureus protein A and expression of the
fusion protein was driven from the RRP4 promoter (39).
Speciﬁcally, the KpnI–EcoRI region was recovered as a
blunt end fragment from p243 by treatment with T4 DNA
polymerase and the klenow fragment of E. coli DNA
polymerase, and blunt-cloned into the EcoRI site at the
end of the zz epitope tag, generating the construct p260
(zz-rrp61-213). To express the N-terminal region of
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p245 encompassing the truncated RRP6 coding region
was cloned into pEG-KT (40).
Yeaststrains and media
The wild-type, rrp6-D::TRP1
Kl (16) and rrp47-D::kan
r null
mutants, and the epitope-tagged rrp47-zz::HIS5
Sp strain
(25) used in this study were derivatives of BMA38 (Mata
ade2-1 his3-D200 leu2-3,112 trp1-1 ura3-1 can1-100) (41).
The rrp47-zz::HIS5
Sp allele had previously been shown to
be fully functional (25). The rrp6-TAP derivative of
BY4741 (Mata his3D1 leu2D0 met15D0 ura3D0) was
obtained from Open Biosystems. This strain showed
vigorous growth at 378C, demonstrating that the
TAP-tagged Rrp6p protein is functional. The rrp6-TAP
rrp47-D::kan
r and rrp47-zz rrp6-D::TRP1
Kl strains were
generated by PCR-mediated mobilization of the rrp47-
D::kan
r or rrp47-zz::HIS5
Sp allele and correct integration
at the RRP47 locus was conﬁrmed by PCR. Yeast strains
expressing the zz-rrp61-213 fusion allele, the corre-
sponding, fully functional full-length Rrp6p derivative
(16) or the GAL-regulated GST-rrp6212-712 fusion
protein were generated by plasmid transformation of
suitable strains. Yeast transformations with plasmids
or PCR-ampliﬁed DNA were performed using standard
techniques. Transformants were selected by growth on
suitable selective media and integrants were screened by
PCR on genomic DNA.
Strains were routinely grown in minimal media contain-
ing 2% glucose or galactose, 0.67% yeast nitrogen base
and appropriate supplements. For spot growth assays, the
relative concentration of URA
+ viable cells in saturated
precultures was ﬁrst determined by plating 100mlo fa1 0
6
dilution on solid glucose-based medium lacking uracil and
counting the number of colonies obtained. Ten-fold serial
dilutions of standardized precultures were prepared and
5ml aliquots were applied to the surface of solid growth
medium and incubated at 26 and 348C for 4 days.
Expression and purification of recombinant proteins
The E. coli strain BL21(DE3)LysS was transformed with
plasmids encoding full-length or truncated GST-Rrp6p
polypeptides and grown up at 308C in LB medium
containing ampicillin and chloramphenicol to an OD600
of 0.5. Transformants expressing His(6)-Rrp47p were
grown up at 378C. Expression was induced by adding
IPTG to 0.5mM and the cultures were incubated for
a further 4h before harvesting the cells. Cell lysates were
prepared by sonication in 20mM HEPES pH 7.6, 300mM
NaCl, 10mM imidazole pH 7.6 and clariﬁed by centri-
fugation at 15000g for 30min. Clariﬁed lysates were
mixed with pre-washed Ni-NTA superﬂow (Qiagen) or
glutathione-sepharose (GE Healthcare) resin and after
extensive washing with lysis buﬀer, the bound proteins
recovered by elution in lysis buﬀer containing 250mM
imidazole or 20mM reduced glutathione. His(6)-Rrp47p
was further puriﬁed by ion exchange chromatography
and gel ﬁltration. The eluate from the Ni-NTA aﬃnity
chromatography was diluted 10-fold with 20mM
HEPES pH 7.6 300mM NaCl to reduce the imidazole
concentration and then mixed with SP-sepharose resin.
Bound His(6)-Rrp47p was eluted with cell lysis buﬀer
containing 500mM NaCl. After concentration under
vacuum, the eluate was resolved through a 25ml superdex
200 column on an A ¨ KTA puriﬁer system (GE Healthcare)
using an elution buﬀer of 20mM HEPES pH 7.6, 300mM
NaCl. Concentrations of protein samples were determined
by Bradford assay.
Protein and RNA analyses
Recombinant protein-binding assays were performed by
mixing lysates from cells expressing one protein with pull-
downs of the partner protein on glutathione-sepharose
or Ni-NTA superﬂow beads. After extensively washing
the beads in lysis buﬀer, retained proteins were eluted,
resolved by SDS–PAGE and visualized by staining with
Coomassie blue G250 or transferred to nylon membrane
and decorated with penta-His monoclonal antibodies
(Qiagen) or anti-GST antiserum (Sigma). Yeast cell lysates
were made in TBS containing 1mM PMSF by glass bead
extraction and clariﬁed by centrifugation at 30 000g for
20min. Yeast fusion proteins carrying two copies of the
z domain of protein A from S. aureus, alone or within
the larger TAP tag, were analysed by western blot using
peroxidase/anti-peroxidase (PAP) antibody (Sigma).
A custom-ordered rabbit polyclonal antiserum raised
against recombinant His(6)-Rrp47p (Eurogentec) was
used at a dilution of 1:5000 for western analyses.
Total cellular RNA was recovered from cells harvested
at early log growth in glucose-based minimal medium
by phenol/GTC extraction using glass beads (25). RNA
was resolved through 8% polyacrylamide gels, transferred
to Hybond N
+ membrane (GE Healthcare) and hybri-
dized with radiolabelled transcript-speciﬁc oligonucleotide
probes to detect speciﬁc RNAs. The probes used in this
study were speciﬁc for the following RNAs: snR38
(oligo 272), gagaggttacctattattacccattcagacagggataactg;
5.8S (oligo 236), gcgttgttcatcgatgc; ITS2 (oligo 237),
tgagaaggaaatgacgct; SCR1 (oligo 242), aaggacccagaac
taccttg.
Protein–nucleic acid-binding assays
Band-shift assays were performed on His(6)-Rrp47p using
EcoRI-digested pBluscript II KS (+) (Stratagene) or the
synthetic homopolymeric RNAs poly(A) and poly(A)–
poly(U) (Sigma). Twenty-microlitre serial dilutions of
Rrp47p puriﬁed from cell lysates by Ni-NTA superﬂow
chromatography were prepared in EMSA buﬀer (10mM
Tris–HCl pH 8, 20mM KCl, 2mM MgCl2, 0.1mM
EDTA, 7% glycerol) and mixed with nucleic acids
on ice for 20min. One microlitre of 30% glycerol-
containing bromophenol blue was then added and the
bound and non-bound nucleic acid fractions were resolved
by electrophoresis through 0.5% agarose gels in 0.5  TBE
at 5V/cm. Resolved nucleic acids were then transferred
to Hybond N
+ membrane and detected by hybridization
with radiolabelled T7 primer (aatacgactcactataggg)
to detect plasmid DNA, or with oligo(dT) to visualize
poly(A).
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or protein complexes were puriﬁed on Ni-NTA or
glutathione-sepharose beads, as described above. The
beads were then equilibrated in EMSA buﬀer containing
150mM NaCl and incubated with radiolabelled ligand
in 50ml of the same binding buﬀer for 30min on ice.
After binding, the supernatant was removed and the beads
were washed three times in binding buﬀer. The amount of
ligand retained on the beads was determined by measuring
the Cherenkov radiation in a Beckman Coulter LS650
scintillation counter. Ligands were labelled at their 50
hydroxyl group with g[
32P]-ATP using polynucleotide
kinase. The ligands used were poly(A), an  40-nt-long
synthetic oligodeoxynucleotide (o280, cggaacctcttgacttt
gagctctatgcacaattcagcttatc), a gel-puriﬁed 40-nt-long
DNA marker (Promega), E. coli tRNA
Phe (Sigma) and
a CIP-treated  0.6-kb long restriction fragment.
Bioinformatics
Rrp6p homologous sequences were identiﬁed by BLAST
searches of the EMBL non-redundant database using
WU-BLASTp2 (http://dove.embl-heidelberg.de/Blast2/).
Multiple sequence alignments was performed using
ClustalW (http://www.ebi.ac.uk/clustalw/index.html) and
viewed using Jalview (42). Protein structure predictions
were performed using PHYRE (http://www.sbg.bio.ic.
ac.uk/ phyre/).
RESULTS
Rrp47p isexpressed as amultimeric protein complex
To purify yeast Rrp47p for in vitro binding assays,
the protein was expressed in E. coli as a 25.5kDa
His(6)-tagged fusion and puriﬁed to near homogeneity
from cell lysates by aﬃnity chromatography using
Ni-NTA superﬂow beads (Figure 1A). The recombinant
protein was further puriﬁed by ion exchange chromato-
graphy over SP-sepharose beads and subjected to gel
ﬁltration analysis. A single peak was observed on the gel
ﬁltration column trace (Figure 1B) that corresponded to
recombinant Rrp47p by SDS–PAGE analysis. The elution
volume of Rrp47p gave an apparent molecular weight of
152kDa (mean and median averages of 10 independent
experiments), indicative of a hexameric complex. We
conclude that Rrp47p is expressed as a multimeric protein
complex that is most probably hexameric.
Rrp47p binds nucleicacids
The murine Rrp47p homologue C1D has been reported
to have in vitro DNA-binding activity (43) and previous
analyses suggested that yeast Rrp47p promotes the
exonuclease activity of Rrp6p by facilitating recruitment
of RNA substrates (25). We therefore tested recombinant
Rrp47p for DNA and RNA binding in a conventional
electrophoretic mobility shift assay (EMSA).
Incubation of plasmid DNA with Rrp47p caused a clear
retardation at protein concentrations of  1mM in the
EMSA (Figure 2A, upper panel). Increased protein
concentrations generated lower mobility complexes
(lanes 8 and 9), most probably due to multiple Rrp47p
complexes associated with the DNA. No retardation was
observed in control experiments where GST protein was
incubated with plasmid DNA under the same conditions
(Figure S1).
We then used this DNA EMSA to test RNAs for their
ability to act as competitor substrates. Incubation in the
presence of poly(A) RNA had little inhibitory eﬀect on the
formation of protein–DNA complexes (Figure 2A, lower
panel), even at 200-fold excess over the plasmid DNA
(the faster migrating material in lane 4 migrates with
protein–DNA complexes seen in the absence of compet-
itor, e.g. upper panel, lane 9). However, incubation in the
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Figure 1. Rrp47p is a multimeric complex. (A) Recombinant
His(6)-Rrp47p puriﬁcation. Samples were resolved through a 15%
SDS–PAGE gel and visualized with Coomassie blue G250. Lane 1,
non-induced cell extract; lane 2, cell extract after 4h induction; lane 3,
Ni-NTA superﬂow eluate; lane 4, SP-sepharose non-bound fraction,
lane 5, SP-sepharose eluate; lane 6, peak fraction from the superdex 200
GF column. The positions of molecular weight markers (in kDa) are
indicated on the left. (B) Gel ﬁltration analysis of the SP-sepharose
retained fraction. The A280 proﬁle is shown, together with the elution
volumes of the markers thyroglobulin (670kDa), g-globulin (158kDa),
ovalbumin (44kDa), myoglobin (17kDa) and vitamin B12 (1.3kDa).
The calibration curve obtained from the molecular weight markers is
shown.
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inhibited DNA binding completely. Titration experiments
revealed that poly(A)–poly(U) was a very eﬃcient binding
competitor, negating DNA binding at approximately
equimolar concentrations (Figure 2B). Competitive inhi-
bition was also observed in the presence of the natural
heteropolymeric RNAs tRNA
Phe from E. coli and total
cellular RNA from yeast (Figure S2). In contrast, single-
stranded DNA oligonucleotides failed to compete for
binding with Rrp47p (Figure S2).
Having established that RNA is an eﬀective competitor
to DNA binding by Rrp47p, we then addressed the ability
of the protein to interact with RNA directly. EMSA
experiments were performed with increasing amounts of
puriﬁed Rrp47p in the presence of poly(A) or poly(A)–
poly(U) RNA and the poly(A) component was detected
by northern hybridization using an oligo(dT) probe.
Consistent with the competitive inhibition EMSA experi-
ments, incubation of poly(A)–poly(U) with Rrp47p
caused a reduced electrophoretic mobility at protein
concentrations of  1mM (Figure 2C). As in the DNA-
binding experiments, slower migrating complexes were
observed at higher protein concentrations. No gel
retardation was observed upon incubation of Rrp47p
with poly(A) RNA.
The EMSA results were corroborated using an on-bead-
binding assay. Double-stranded DNA and tRNA were
retained on beads coated with His(6)-Rrp47p, while there
was no signiﬁcant binding of poly(A) or single-stranded
DNA oligonucleotide (Figure S3). We conclude that
Rrp47p binds to double-stranded DNA or structured
RNA with comparable aﬃnity, with an apparent
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Figure 2. Rrp47p is a nucleic acid-binding protein. (A) DNA EMSA. Upper panel, 50ng linearized plasmid was incubated with 2-fold increasing
amounts of IMAC-puriﬁed, recombinant Rrp47p over the indicated concentration range. Free and bound forms were resolved by agarose gel
electrophoresis and detected by Southern blot hybridization (see Materials and Methods section). Lower panel, EMSA in the presence of competitor
RNA. Lane 1, free DNA substrate; lane 2, DNA and Rrp47p; lane 3, DNA and mock-puriﬁed protein from a pre-induced culture; lane 4, DNA,
Rrp47p and 10mg poly(A); lane 5, DNA, Rrp47p and 10mg poly(A)–poly(U). (B) Titration of competitor RNA in EMSA. Mixes contained 50ng
DNA, 5mM Rrp47p and 2-fold increasing amounts of RNA over the indicated concentration range. Upper panel, poly(A); Lower panel, poly(A)–
poly(U). (C) RNA EMSA with poly(A) (left) or poly(A)–poly(U) (right). One hundred nanogram of RNA was incubated 2-fold increasing amounts
of Rrp47p over the indicated range. The mixtures were resolved by agarose gel electrophoresis and the poly(A) RNA was detected by northern blot
hybridization.
5560 Nucleic Acids Research, 2007, Vol. 35, No. 16dissociation constant in the 1mM range, and shows no
detectable interaction with single-stranded nucleic acids.
Rrp47p directly binds Rrp6p invitro
Rrp47p has previously been shown to be a component
of the Rrp6p-containing exosome complex (25,26) but
previous studies have not addressed whether the proteins
physically interact. To demonstrate a putative direct
interaction, Rrp6p was expressed in E. coli as an
N-terminal GST fusion protein and assayed for its ability
to bind His(6)-Rrp47p in pull-down assays (see Materials
and Methods section). The His tag antibody detected an
 25kDa protein in pull-downs of lysates containing
GST-Rrp6p and His(6)-Rrp47p (Figure 3A). No signal
was observed if lysate from cells expressing GST was used,
or if bound GST-Rrp6p was incubated with lysate from
cells transformed with the control vector pRSETB.
Speciﬁc binding between His(6)-Rrp47p and GST-Rrp6p
was also observed in the reciprocal pull-down experiment
on Ni-NTA beads (data not shown). We conclude that
Rrp47p interacts directly with Rrp6p in the absence of
other exosome proteins.
To map the Rrp47p-binding site within the 84kDa
Rrp6p protein, deletion constructs of Rrp6p were made
(Figure 3B) and their ability to interact with His(6)-
Rrp47p was compared with that of full-length Rrp6p in
pull-down assays. The GST-Rrp6212-721 mutant
contains the N-terminal region of Rrp6p without the
catalytic domain, the HRDC domain and the C-terminal
domain bar 12 residues at the extreme C-terminus.
In contrast, the GST-Rrp642-450 construct contains
the complete C-terminal domain and most of the HRDC
domain, but not the catalytic domain and the N-terminal
region bar the extreme N- terminus. His(6)-Rrp47p was
retained on beads charged with full-length GST-Rrp6p or
the GST-Rrp6212-721 mutant (Figure 3C, lanes 1 and 2)
but no binding was observed with the GST-Rrp642-450
construct (Figure 3C, lane 3). A GST-Rrp6p fusion
lacking only residues 1–212 (GST-Rrp61-212) also
failed to show Rrp47p-binding activity (Figure 3D).
Although the expression levels of the N-terminal deletion
constructs were low, compared with fragments containing
the N-terminal region, there was absolutely no detectable
binding of His(6)-Rrp47p after prolonged exposure times
while binding to the full-length construct was easily
detectable. We conclude that the N-terminal 212 residues
of Rrp6p are both necessary and suﬃcient for binding
to Rrp47p in vitro.
Analysis ofthe PMC2NT domain
To analyse the N-terminal 212 residues of Rrp6p in more
detail, homologues were identiﬁed by BLAST searches
and the sequences aligned using ClustalW (Figure S4).
All Rrp6p homologues contained a common N-terminal
domain that is not found in other subgroups of the DEDD
family of 30->50 exonucleases. Previous bioinformatics
analyses (33) suggested that residues 13–102 of Rrp6p
constitute an independent domain, denoted PMC2NT
(shown schematically in Figure 4). Protein structure
prediction programmes indicated that the PMC2NT
domain is largely a-helical in nature, while residues
103–212 have low structural content. However, a recent
structural analysis of residues 129–536 of yeast Rrp6p (37)
revealed four short a-helices at positions 132–135,
162–165, 184–189 and 208–210 (denoted a1–a4i n
Figure 4 and Figure S4). The multiple sequence alignment
(Figure S4) indicates that the regions of the protein
between a1 and a2 (residues 129–162 in Saccharomyces
cerevisiae Rrp6p), and around a3 (residues 179–197)
contain a number of highly conserved residues.
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Figure 3. Rrp47p binds directly to the N-terminal region of Rrp6p.
(A) Rrp47p co-puriﬁes with Rrp6p in pull-down assays. Glutathione-
sepharose beads were incubated ﬁrst with lysate containing recombi-
nant GST–Rrp6p or GST and then with lysate from cells expressing
His(6)-Rrp47p or containing the control vector pRSETB. Eluates were
resolved through a 10% SDS–PAGE gel and analysed by western
blotting using an antibody speciﬁc for the His tag. O denotes the top of
the resolving gel; X marks the position of the bromophenol blue
tracking dye. (B) Schematic of the domain structure of Rrp6p.
PMC2NT, exonuclease (EXO) and HRDC domains are indicated as
boxes. Deletions within Rrp6p constructs made in this study are
indicated by broken lines. (C and D) Western analyses of eluates from
pull-down assays performed using diﬀerent Rrp6p constructs, as in A.
Upper panels show western blots of eluates using an anti-GST
antibody; lower panels show corresponding results with an anti-His
antibody. Multiple bands are visible with the anti-GST antibody due to
proteolytic degradation of Rrp6p. The electrophoretic migration of the
full-length Rrp6p protein constructs are indicated to the right of
the panels.
Nucleic Acids Research, 2007, Vol. 35, No. 16 5561To assay whether the PMC2NT domain was suﬃcient
for Rrp47p binding, we expressed residues 13–102 of
Rrp6p as a GST fusion protein in E. coli and assayed
the recombinant protein for Rrp47p-binding activity,
as above. As shown in Figure 4B, the PMC2NT domain
of Rrp6p alone is suﬃcient for Rrp47p binding. However,
increased levels of His(6)-Rrp47p were observed in pull-
downs of Rrp6p fusion proteins that extend up to P176 or
L197 (compare Figure 4, lane 2 with lanes 3–5). This eﬀect
is not simply due to diﬀerences in the expression levels of
the diﬀerent Rrp6p constructs, since the fusion protein
extended to L197 is expressed at lower levels than the
PMC2NT fusion (Figure 4B upper panel, lanes 2 and 4).
We conclude that the PMC2NT domain is suﬃcient for
binding with Rrp47p, and that residues between 103 and
197 contribute to this interaction.
Rrp47pbinds both nucleicacid andRrp6p concomitantly
To address whether Rrp47p binding to Rrp6p and nucleic
acid is mutually exclusive or can occur simulta-
neously, we carried out RNA- and DNA-binding
assays on pull-downs of Rrp6p/Rrp47p complexes.
Glutathione-sepharose beads were charged with either
the N-terminal Rrp6p expression construct (GST-
Rrp6212-721) or GST and then incubated with lysate
containing His(6)-Rrp47p or a control extract. The beads
were then incubated with radiolabelled nucleic acids
(tRNA
Phe or a DNA restriction fragment), the non-
bound fraction removed and the amount of bound ligand
quantiﬁed (Figure 5). Binding of both tRNA
Phe and DNA
was observed for the assembled Rrp6p–Rrp47p complex.
No signiﬁcant binding was observed in the absence of
His(6)-Rrp47p, consistent with the lack of nucleic acid-
binding activity of GST or GST-Rrp6212-721
(Figure S1). Moreover, binding was dependent upon
the presence of the truncated GST-Rrp6p fusion.
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Figure 4. Residues C-terminal to the PMC2NT domain contribute to
Rrp47p interaction. (A) Schematic of the N-terminal region of Rrp6p.
The location of the PMC2NT domain and the four short a-helices
a1–a4 are shown. Residues P176 and L197 deﬁne the C-termini of
truncated Rrp6p constructs. These residues are mutated to stop codons
and therefore not the C-terminal residues. (B) Pull-down assay of
His(6)-Rrp47p with GST-tagged N-terminal Rrp6p fragments. Eluates
from glutathione-sepharose beads were resolved by SDS–PAGE and
assayed by western blot analyses with primary antisera against GST
(upper panel) or the His tag (lower panel). Electrophoretic mobilites of
protein molecular weight markers (in kDa) are given on the left.
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Figure 5. Rrp47p interacts with nucleic acid when bound to Rrp6p.
Glutathione-sepharose beads charged with GST or a GST fusion
protein containing the N-terminal region of Rrp6p (GST-Rrp6212-
721) were incubated with lysate containing His(6)-Rrp47p or a control
extract (pRSETB). After washing the beads, protein complexes were
incubated with radiolabelled E. coli tRNA
Phe or a DNA restriction
fragment. The non-bound material was removed and bound tRNA or
DNA was determined by quantifying the associated Cherenkov
radiation. (A) Levels of tRNA retained. (B) Levels of DNA retained.
The results shown are the average of three independent assays,
the error bars indicating the associated range.
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a stable complex with structured nucleic acids.
The N-terminal region ofRrp6p is requiredfor
normal levelsof Rrp47p
There is no available data regarding Rrp47p expression
levels, although the levels of several other exosome
components such as Rrp6p have been determined (44).
We therefore compared the expression levels of Rrp47p
and Rrp6p proteins fused to the same epitope (two copies
of the z domain of S. aureus protein A) by western blot
analysis. We also addressed whether the expression level
of Rrp47p was dependent upon Rrp6p.
Western blot analyses revealed that the expression levels
of Rrp47p-zz and Rrp6p-TAP in yeast cells were compar-
able (Figure 6A, compare lanes 1 and 3). The expression
level of Rrp47p–zz was reduced to very low levels in the
absence of Rrp6p (Figure 6A, lanes 1 and 2). In contrast,
the expression of Rrp6p-TAP was not signiﬁcantly
sensitive to the level of Rrp47p (Figure 6A, and 25). We
conclude that Rrp6p is required for the normal accumula-
tion of Rrp47p. Since Rrp47p binds directly to the
N-terminal region of Rrp6p in vitro (Figures 3 and 4),
we reasoned that its interaction with Rrp6p was required
for the accumulation of Rrp47p in the cell. To test this
hypothesis, we determined Rrp47p-zz expression levels in
yeast rrp6 deletion mutants speciﬁcally lacking the
N-terminal region of the protein (rrp6D1-213)o rc o m p r i s -
ing essentially just the N-terminal region (rrp6D212-721).
The rrp6D1-213 mutant was expressed as a zz tag fusion to
allow a direct comparison of the relative expression levels
of Rrp6p and Rrp47p proteins, while the rrp6D212-721
mutant was expressed as a GST fusion to test for
association with Rrp47p in pull-down assays. The GST-
Rrp6212-721 protein was expressed in yeast under the
control of the inducible GAL promoter, allowing repression
during growth in glucose-based glucose-based medium and
induction during growth in galactose-based medium.
Rrp6p was expressed at similar levels as a C-terminal
TAP tag or an N-terminal zz tag (Figure 6B), and the
N-terminal deletion did not signiﬁcantly aﬀect the
expression level of the protein (Figure 6C). As observed
above, a very low level of expression of Rrp47p-zz was
detected in the rrp6- strain (Figure 6C, lane 1).
Expression of full-length zz-Rrp6p resulted in the accu-
mulation of a band of identical electrophoretic mobility
to Rrp47p-zz (Figure 6C, compare lanes 1 and 2).
The observed levels of this band were comparable to
that of zz-Rrp6p and a band of this size was not observed
in strains expressing zz-Rrp6p as the only epitope-tagged
protein (Figure 6B, lane 2). In contrast, this protein did
not accumulate in strains expressing Rrp6p that lacked the
N-terminal region (Figure 6C, lane 3). Rrp47p-zz levels in
an rrp6- strain were signiﬁcantly increased upon induc-
tion of GST-Rrp6212-721 (Figure 6D, compare lanes 5
and 6) but not in the vector control (Figure 6D, lanes 3
and 4). We conclude that the N-terminal region of Rrp6p
is necessary and suﬃcient for normal expression levels
of Rp47p in yeast.
An interaction between Rrp47p and the N-terminal
region of Rrp6p in yeast extracts was demonstrated in
pull-down assays. Lysate from strains expressing either
GST or the GST-Rrp6p211-721 fusion were incubated
with glutathione-sepharose beads and the eluates analysed
on western blots using the GST-speciﬁc antibody or a
rabbit polyclonal antiserum raised against recombinant
His(6)-Rrp47p. Rrp47p was detected in the pull-down
from the strain expressing the GST-Rrp6212-721 fusion
but not the GST control (Figure 6F). We conclude that
the N-terminal region of Rrp6p is suﬃcient for Rrp47p
interaction in yeast cell extracts.
TheN-terminalregionofRrp6pisrequiredfornormalgrowth
Yeast rrp6- mutants have a ts-lethal growth phenotype
and show slow growth at permissive temperatures (34),
while rrp47- mutants exhibit a more moderate non-
conditional growth defect. To analyse the contribution of
the N-terminal region of Rrp6p to the function of the
protein in vivo, we ﬁrst assayed the growth of cells
expressing the truncated Rrp6p protein. Yeast rrp6-
strains transformed with plasmids expressing the mutant
zz-rrp6D1-213 allele, the full-length zz-Rrp6p protein
or the empty cloning vector were grown on selective
solid growth medium or in liquid culture and their growth
characteristics were compared with that of an isogenic
rrp47- mutant and the parental wild-type strain.
Spot growth assays revealed that both the full-length
zz-Rrp6p protein and the truncated zz-rrp6D1-213
allele complemented the ts-lethal growth phenotype of
the rrp6- mutant (Figure 7A). To compare the growth
phenotypes of the zz-rrp6D1-213 and rrp47- strains
further, we directly measured their growth rates at 308C,
the standard laboratory growth temperature for S.
cerevisiae, and compared them to rrp6- and wild-type
strains (Figure 7B). The doubling times of the wild-type
strain and the rrp6- mutant complemented by the full-
length zz–Rrp6p construct were 175min and 163min,
respectively. Growth of the rrp47- and zz-rrp6D1-213
mutants was comparably impaired, with doubling times of
200min and 223min, respectively. The rrp6- mutant
grew considerably more slowly, with a doubling time of
319min. We conclude that the zz-rrp6D1-213 allele
encodes a functional Rrp6p protein that supports
growth at a level close to that observed upon loss of
Rrp47p function.
The N-terminal region of Rrp6p isrequired for5.8S rRNA
andsnoRNA processing
Yeast strains lacking Rrp6p or Rrp47p accumulate 30
extended forms of 5.8S rRNA and snoRNAs (4,5,25,34).
To test the role of the N-terminal region of Rrp6p in
stable RNA processing pathways, total cellular RNA
isolated from the zz-rrp6D1-213 mutant, the isogenic
wild-type strain, a strain expressing full-length zz-Rrp6p
and rrp6- or rrp47- null mutants was analysed by
northern blot hybridization using oligonucleotide probes
complementary to the mature 5.8S rRNA, 30 extended
5.8S rRNA species, and the intron-encoded box C/D
snoRNA snR38.
Nucleic Acids Research, 2007, Vol. 35, No. 16 5563The zz-rrp6D1-213 mutant exhibited a 5.8S rRNA
processing phenotype that was comparable to that
of rrp6- and rrp47- mutants (Figure 8A, lanes 3–5),
with a slight increase in the level of 7S pre-rRNA, the
30 extended precursor to 5.8S rRNA, compared to the
wild-type strain, and a large accumulation of the
‘5.8S+30’ processing intermediate. A much weaker
accumulation of the band corresponding to the 5.8S+30
intermediate was observed in cells expressing the full-
length zz-Rrp6p epitope-tagged protein (Figure 8A,
lane 2), demonstrating that the defect observed in
the mutant lacking the N-terminal region is not due to
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Figure 6. Rrp47p interacts with the N-terminal region of Rrp6p in yeast. (A–D) Western analyses of cell extracts from strains expressing epitope-
tagged forms of Rrp47p and/or Rrp6p. Extracts were resolved through 10% SDS–PAGE gels, protein transferred to western blots and the fusion
proteins detected using PAP or GST-speciﬁc antisera. Relevant strain genotypes are indicated above each lane. The rrp47-zz, rrp6-TAP and zz-rrp6
alleles encode full-length fusion proteins, whereas the zz-Rrp61-213 and the GST-Rrp6212-721 proteins are truncated Rrp6p variants. The GST
fusion proteins were expressed under the control of the GAL promoter; panel D shows analyses of extracts from strains grown in glucose-based
media (glc) and in galactose-based media (gal). The upper panel in D shows a western analysis using the GST-speciﬁc antibody. The centre panel in
D shows a western analysis of the same samples using the PAP antibody. Bands corresponding to the detected fusion proteins are indicated on the
right. SDS–PAGE analyses (lower panels) indicate the relative loading of each extract. (E) Western analysis of lysates from isogenic wild-type and
rrp47- strains, using a His(6)-Rrp47p antiserum. Proteins were resolved through a 15% SDS–PAGE gel. The migration of size markers (in kDa) is
indicated on the left. A strong band of the expected size is detected in the wild-type lysate (lane 1) and absent in the rrp47-D extract (lane 2).
(F) Western analyses of the bound fractions of extracts from strains expressing GST (lane 1) or GST-Rrp6212-721 (lane 2) after incubation with
glutathione-sepharose beads. The upper panel shows a blot probed with the GST-speciﬁc antibody, the lower panel shows a blot probed with the
His(6)-Rrp47p antiserum.
5564 Nucleic Acids Research, 2007, Vol. 35, No. 16the presence of the epitope tag. The zz-rrp6D1-213 mutant
also accumulated snR38 species that were  3nt longer
than the mature RNA (denoted snR38+3) or extended
to the 30 splice site (denoted snR38-30). A similar defect
was also observed for U14 snoRNA (data not shown).
The snoRNA processing phenotype of rrp6- mutants
is more exacerbated than that of rrp47- mutants,
as demonstrated by the complete block to ﬁnal trimming
of snR38 (Figure 8B, compare lanes 3 and 4, and 25). The
snR38-processing defect observed in the zz-rrp6D1-213
mutant matched that observed in the rrp6- null mutant.
We conclude that loss of the N-terminal domain of Rrp6p
elicits stable RNA-processing phenotypes that are con-
sistent with a loss of Rrp47p function. However, loss of
the N-terminal region of Rrp6p has a more severe eﬀect
on the protein’s function than simply abrogating its
interaction with Rrp47p.
DISCUSSION
To test an earlier model that Rrp47p functions as an
exosome cofactor by docking the Rrp6p enzyme onto
the 30 end of RNA substrates (25), we assayed Rrp47p
for its ability to bind RNA and to interact with Rrp6p.
Recombinant Rrp47p was shown to bind concomitantly
to both RNA and Rrp6p. The region of Rrp6p involved
in Rrp47p binding was mapped to the functionally
uncharacterized N-terminal PMC2NT domain (33) and
we therefore addressed the contribution of this domain
to Rrp6p activity in vivo.
Rrp47p bound poly(A)–poly(U) and tRNA
Phe but did
not bind poly(A) RNA, and bound to structured RNA or
double-stranded DNA with comparable aﬃnity in EMSA
analyses. Rrp47p is not related in sequence to any
characterized double-stranded nucleic acid-binding
protein (45) and therefore represents a novel class of
proteins with this activity. Analysis of the protein
sequence using the structure prediction algorithms
PHYRE (http://www.sbg.bio.ic.ac.uk/ phyre/) and
PSIPRED (http://bioinf.cs.ucl.ac.uk/psipred/) suggest
that Rrp47p and its homologues consist of an a-helical
N-terminal region, followed by an unstructured region
of variable length which has a basic stretch of residues
at the C-terminus (50% lysine or arginine residues
in the ﬁnal 22 amino acids of S. cerevisiae Rrp47p).
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Figure 7. Loss of the N-terminal region of Rrp6p elicits a slow growth
phenotype comparable to rrp47- mutants. Growth of isogenic rrp6-,
zz-rrp6, zz-rrp6D1-213, rrp47- and wild-type strains were compared
on selective solid or liquid growth medium. (A) Spot growth assays.
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(non-permissive for growth of rrp6- strains) and the plates photo-
graphed after 4 days. (B) Growth curves. Cultures grown at 308C were
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is plotted against time.
wild-type
zz-rrp6
5.8S+30
5.8S+30
5.8S
7S
A
123 4 5
SCR1
snR38+3
snR38
snR38-3′
123 4 5
wild-type
zz-rrp6
B
snR38+3
snR38
∆
∆
∆
∆
∆ ∆
Figure 8. The N-terminal region of Rrp6p is required for 5.8S rRNA
and snoRNA processing. Northern blot analyses of RNA in the
zz-rrp6D1-213 mutant. Total cellular RNA from yeast cultures was
resolved through 8% denaturing acrylamide gels and analysed by
northern blot hybridization using probes speciﬁc to 5.8S rRNA and
snR38 RNA species. Relevant strain genotypes are indicated above
each lane. Detected RNA species are indicated to the right of each
panel. (A) Hybridization with probes to 5.8S rRNA species. Upper
panel, hybridization with a probe (237) speciﬁc for 30 extended 5.8S
rRNA species. Centre panel hybridization with a probe (236) speciﬁc
for the mature 5.8S rRNA. 5.8S rRNA is expressed as a predominant
short form and a less abundant long form. Lower panel hybridization
with a probe (242) complementary to the RNA pol III transcript SCR1,
which serves as a loading control. (B) Hybridization with a probe (272)
speciﬁc for snR38. Lower panel, exposure showing the mature snR38
and a species with a short 30 extension (snR38+3). Upper panel, longer
exposure to reveal 30 extended precursors. The snR38 species extended
at the 30 end to the 30 splice site is indicated as snR38-30.
Nucleic Acids Research, 2007, Vol. 35, No. 16 5565Residues within this lysine-rich region might contribute to
nucleic acid binding (46) but the nature of the speciﬁcity
for double-stranded nucleic acids is unclear at present.
Rrp47p may potentially form a collar around double-
stranded DNA or RNA, analogous to some members of
the six-membered ring ATPase family (47). Consistent
with our results, the Rrp47p homologue C1D has recently
been reported to bind structured RNAs such as poly(G)
and tRNA in vitro (48).
The RNA-binding activity of Rrp47p is most probably
of key importance to its function as an exosome cofactor.
The 30 termini of 5.8S rRNA and snoRNA precursors
that accumulate in rrp6- and rrp47- strains are
predicted to be involved in imperfect double-stranded
structures (49,50). In addition, recent genome-wide
expression studies have revealed extensive transcription
of both intergenic regions and antisense mRNA (51–53),
which could hybridize with mRNA to form stretches of
double-stranded RNA. Such intergenic transcripts are
nuclear exosome substrates (20) and are degraded in an
Rrp47p-dependent manner (27). Furthermore, recombi-
nant Rrp6p is highly active on poly(A) or A/U-rich RNAs
in vitro but degrades structured substrates rather poorly
(11,17). Rrp47p has also been implicated in processes
of DNA repair (38,54) and telomere length control (55),
which may reﬂect its ability to bind DNA.
Previous estimates suggest Rrp6p is present at  2000
copies per cell (44). Our western analyses revealed
comparable expression levels of Rrp47p and Rrp6p.
The organization of Rrp47p into hexameric complexes
suggests that the majority of Rrp6p–exosome complexes
in the cell do not contain Rrp47p, a notion supported
by the stoichiometric levels of Rrp47p and Rrp6p in
non-fractionated exosome complexes (25). One possibility
is that Rrp6p-containing exosome complexes lacking
Rrp47p are required for the Rrp47p-independent function
of Rrp6p that is important for optimal cell growth.
Recombinant protein studies and analyses of yeast
extracts showed that Rrp47p interacts with the
 200-residue long N-terminal region of Rrp6p. While
the PMC2NT domain of Rrp6p (residues 13–102) was
suﬃcient for Rrp47p interaction, binding was improved
with extended constructs. Sequence alignments and
structural studies (37) reveal that this region includes
a semi-conserved loop ﬂanked by short a-helices
(P132-L166). We propose that this loop structure
promotes binding of Rrp47p to the PMC2NT domain,
either by stabilizing the fold of the PMC2NT domain
or by providing additional points of interaction. Further-
more, expression of an rrp6 mutant lacking the N-terminal
region correlated with loss of Rrp47p function in vivo by
three independent criteria: (i) the depletion of Rrp47p
expression levels; (ii) a reduction of cell growth rate;
and (iii) the accumulation of 5.8S rRNA and snoRNA
processing intermediates. C1D has recently been shown to
interact with both RNA and PM/Scl-100 (48), the human
homologue of Rrp6p, demonstrating that this mode of
exosome regulation has been conserved from yeast to
humans.
Deletion of the N-terminal region had a greater eﬀect
on Rrp6p function than simply preventing interaction
with Rrp47p. Loss of the N-terminal region of Rrp6p may
cause subtle structural defects within the protein; it has
been proposed that this region may be important to
anchor the HRDC domain to the exonuclease domain
(37). Alternatively, additional factors involved in snoRNA
maturation such as Bcd1p (26) might also interact with
this portion of Rrp6p.
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